Effects of rTMS Combined With Dual-Task Gait Training on Walking and Cognition After Stroke
Effects of Dorsolateral Prefrontal Cortex rTMS Primed Dual-Task Gait Training on Walking and Cognitive Outcomes After Stroke: A Randomized Sham-Controlled Trial
The Hong Kong Polytechnic University
184 participants
Jan 21, 2026
INTERVENTIONAL
Conditions
Summary
This randomized, double-blind, placebo-controlled trial will investigate whether repetitive transcranial magnetic stimulation (rTMS) applied to the dorsolateral prefrontal cortex (DLPFC) can enhance the effects of dual-task gait training in people with chronic stroke. Participants will be randomly allocated to receive either active rTMS or sham rTMS immediately before the same standardized dual-task gait training program. The intervention includes 12 sessions over 3 weeks. Outcomes will be assessed at baseline, immediately after training, and at 4-week follow-up. Co-primary outcomes are dual-task mobility and cognitive performance during walking, quantified using dual-task cost (DTC) for gait speed and cognitive-task performance during dual-task walking (e.g., Serial 7s; Shopping List Recall). Secondary outcomes include balance/mobility, community participation, mood/sleep measures, and fall incidence. To explore mechanisms, prefrontal cortex activity during single- and dual-task walking will be recorded using functional near-infrared spectroscopy (fNIRS), and mediation analyses will examine whether changes in PFC activity explain intervention effects.
Eligibility
Inclusion Criteria8
- Unilateral ischemic or hemorrhagic hemispheric stroke
- Age ≥ 50 years
- ≥ 6 months post-stroke
- Medically stable
- Able to walk independently ≥ 1 minute (assistive device allowed)
- Able to follow commands
- mRS 1-3
- MoCA ≥ 22
Exclusion Criteria9
- Other neurological disorders
- Cerebellar/brainstem injury
- TMS contraindications (e.g., pacemaker, intracranial metal, seizure history, pregnancy)
- Contraindications to exercise (e.g., unstable angina)
- Severe aphasia (NIHSS item 9 ≥ 2)
- Pain/illness limiting performance
- Concurrent formal rehabilitation elsewhere
- RMT cannot be determined
- Fails TMS safety screening
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Participants will receive active rTMS targeting the DLPFC of the affected hemisphere before each training session: 5 Hz, 90% resting motor threshold (RMT), 10-second trains with 30-second inter-train intervals, total 1,200 pulses (≈ 16 minutes) per session. Dual-task gait training will start within \~10 minutes after rTMS. The program includes 12 sessions over 3 weeks.
Participants will receive sham rTMS delivered using the placebo side of the same coil at the same DLPFC target location and with identical session duration and procedures (≈ 16 minutes) before each training session. Dual-task gait training will start within \~10 minutes after sham stimulation. The program includes 12 sessions over 3 weeks.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07356687